O-4310 (1-isopropyl-6-fluoro-psilocin) is a tryptamine derivative developed by Organix Inc which acts as a serotonin receptor agonist. It is claimed to have an EC50 of 5 nM at the 5-HT2A receptor with 89% efficacy relative to serotonin, and 100-fold selectivity over the 5-HT2C receptor, while being apparently inactive at the 5-HT2B antitarget.[1][2]
Clinical data | |
---|---|
Other names | 1-Isopropyl-6-fluoro-psilocin |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H21FN2O |
Molar mass | 264.344 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ US 7655691, Kumaran G, Morency C, Roth B, Sard HP, Shuster L Xu L, "Indole compounds useful as serotonin selective agents.", published 11 May 2006, assigned to Organix Inc
- ^ Motaghinejad O, Motaghinejad M, Motevalian M, Rahimi-Sharbaf F, Beiranvand T (October 2017). "The effect of maternal forced exercise on offspring pain perception, motor activity and anxiety disorder: the role of 5-HT2 and D2 receptors and CREB gene expression". Journal of Exercise Rehabilitation. 13 (5): 514–525. doi:10.12965/jer.1734992.496. PMC 5667597. PMID 29114525.